The ADP/ATP ratio: A novel predictive assay for quality assessment of isolated pancreatic islets

American Journal of Transplantation

Volumn 6, Issue 10, 2006, Pages 2483-2487

  Goto, M ^a   Holgersson, J ^b   Kumagai Braesch, M ^b,c   Korsgren, O ^d  

^a TOHOKU UNIVERSITY   (Japan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

ADP ATP ratio; Adult porcine islets; Islet transplantation; Viability

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; DNA; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CELL CULTURE; CELL LOSS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNE DEFICIENCY; INSULIN RELEASE; ISOLATED PANCREAS ISLET; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS ISLET TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; QUALITY CONTROL; STREPTOZOCIN DIABETES; SWINE; TREATMENT OUTCOME;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; HYPERGLYCEMIA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, NUDE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SWINE;

EID: 33748498730     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01474.x     Document Type: Article

References (21)

1. Hering BJ, Kandaswamy R, Ansite JD et al. Single-donor,marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-835.
2. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
3. Tsujimura T, Kuroda Y, Avila JG et al. Influence of pancreas preservation on human islet isolation outcomes: Impact of the two-layer method. Transplantation 2004; 78: 96-100.
4. Lakey JR, Helms LM, Kin T et al. Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation 2001; 72: 565-570.
5. Barnett MJ, McGhee-Wilson D, Shapiro AM, Lakey JR. Variation in human islet viability based on different membrane integrity stains. Cell Transplant 2004; 13: 481-488.
6. Gerling IC, Kotb M, Fraga D, Sabek O, Gaber AO. No correlation between in vitro and in vivo function of human islets. Transplant Proc 1998; 30: 587-588.
7. Eckhard M, Brandhorst D, Winter D et al. The role of current product release criteria for identification of human islet preparations suitable for clinical transplantation. Transplant Proc 2004; 36: 1528-1531.
8. Ricordi C, Scharp DW, Lacy PE. Reversal of diabetes in nude mice after transplantation of fresh and 7-day-cultured (24 degrees C) human pancreatic islets. Transplantation 1988; 45: 994-996.
9. Hering BJ, Kandaswamy R, Harmon JV et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004; 4: 390-401.
10. Bradbury DA, Simmons TD, Slater KJ, Crouch SP. Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis. J Immunol Methods 2000; 240: 79-92.
11. Wennberg L, Song Z, Bennet W et al. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days. Transplantation 2001; 71: 1024-1033.
12. Goto M, Eich TM, Felldin M et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004; 78: 1367-1375.
13. Elmer DS, Hathaway DK, Bashar Abdulkarim A et al. Use of glucose disappearance rates (kG) to monitor endocrine function of pancreas allografts. Clin Transplant 1998; 12: 56-64.
14. Balamurugan AN, He J, Guo F et al. Harmful delayed effects of exogenous isolation enzymes on isolated human islets: Relevance to clinical transplantation. Am J Transplant 2005; 5: 2671-2681.
15. Ichii H, Inverardi L, Pileggi A et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005; 5: 1635-1645.
16. Sweet IR, Khalil G, Wallen AR et al. Continuous measurement of oxygen consumption by pancreatic islets. Diabetes Technol Ther 2002; 4: 661-672.
17. Sweet IR, Gilbert M, Jensen R et al. Glucose stimulation of cytochrome C reduction and oxygen consumption as assessment of human islet quality. Transplantation 2005; 80: 1003-1011.
18. Sweet IR, Cook DL, DeJulio E et al. Regulation of ATP/ADP in pancreatic islets. Diabetes 2004; 53: 401-409.
19. Ishii S, Sato Y, Terashima M et al. A novel method for determination of ATP, ADP, and AMP contents of a single pancreatic islet before transplantation. Transplant Proc 2004; 36: 1191-1193.
20. Moberg L, Johansson H, Lukinius A et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039-2045.
21. Johansson H, Lukinius A, Moberg L et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54: 1755-1762.